Home

Warmte Sport Verslaving kevin harrington icr Absorberen aardappel Oven

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal  Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel  Prize for Physiology or Medicine being awarded to
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to

Professor Kevin Harrington - YouTube
Professor Kevin Harrington - YouTube

Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI  - YouTube
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube

The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will  present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV  expressing an anti-CTLA-4 antibody as a single agent and combined
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined

Cancer: Scientists aim to double survival within a decade | The Independent
Cancer: Scientists aim to double survival within a decade | The Independent

ICR Discovery Club showcases how we combine therapies to target  hard-to-treat cancers - The Institute of Cancer Research, London
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London

ICR calls for improved biomarker cancer tests to help personalise treatment  - PMLiVE
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE

The ICR on Twitter: "Professor Kevin Harrington specialises in  #HeadAndNeckCancer. He and his team study the use of biologically targeted  agents, in combination with treatments such as #Radiotherapy and  #Chemotherapy, to target #
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #

Radiotherapy supercharges cancer-targeting viruses to treat deadly skin  cancer - The Institute of Cancer Research, London
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London

The ICR on Twitter: "Professor Kevin Harrington explained the basic  principles of using viruses to treat cancer and talked about the  cancer-killing virus therapy, T-VEC. Find out more about how viral  immunotherapies
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies

Royal Marsden researchers named among world's most influential scientists |  The Royal Marsden
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden

High-tech radiotherapy, drug combinations and immunotherapy showcased as  future of cancer treatment - The Institute of Cancer Research, London
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London

The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR +  @royalmarsdenNHS) featured earlier in a @BBCr4today segment on  #immunotherapy. In the UK you can still listen to today's live program
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as  he shares more on how a modified version of the herpes virus could offer  hope for some people with advanced #Cancer.
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.

ICR researchers named among world's most influential scientists - The  Institute of Cancer Research, London
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London

Connections blog - ICR celebrates innovation and commercialisation at staff  awards - The Institute of Cancer Research, London
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London

Professor Kevin Harrington | The Royal Marsden
Professor Kevin Harrington | The Royal Marsden

The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the  @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR  #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

Statement about NICE decision on T-VEC for treating inoperable metastatic  melanoma | The Royal Marsden
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden

Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London

Tumour assassination – using smart targeted treatments to enhance  anti-cancer radiation responses - The Institute of Cancer Research, London
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London

Scientists reveal new lines of attack to raise cancer survival rate |  Cancer research | The Guardian
Scientists reveal new lines of attack to raise cancer survival rate | Cancer research | The Guardian

Using imaging to predict and improve responses to immunotherapy - Oracle  Cancer Trust
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust